RadNet, Inc. (RDNT) stock
RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3058% above fair value
$74.92−1.97 (-2.56%)
Close on Nov 17, 2026Market cap $5.90BP/E –Yield –
RadNet r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for RadNet
RadNet has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?